Four TÜBİTAK Projects of Assoc. Prof. Dr. Serdar Durdağı Accepted

The projects submitted in September 2014 by Assoc. Prof. Dr. Serdar Durdağı, faculty member at the Division of Biophysics, Department of Basic Medical Sciences, BAU School of Medicine, titled "Investigation of the Physicochemical and Biological Properties of Structure-Based Designed Oxazolone and Imidazolone Derivatives as Next-Generation Antihypertensive Molecules by Molecular Modeling and Biophysical Methods, and Analysis of Their Possible Inhibitory Effects on Cell Proliferation" and "Inhibition of Biofilm Formation by Propionibacterium acnes, a Causative Agent of Acne Vulgaris, Using Secondary Metabolites Isolated from Lichen Species," have been accepted under the TÜBİTAK-1001 Research Support Programs Directorate (ARDEB).

Assoc. Prof. Dr. Serdar Durdağı will also take part as a researcher in the accepted project under the TÜBİTAK-1003 Priority Areas R&D Projects Support Program titled "Development of a Cell-Based Influenza Prototype Vaccine Using Reverse Genetics and Synthetic Biology Methods" . 

In addition to these accepted projects, through Dr. Durdağı's project titled "Development of New Targets against Dengue Virus with Computer-Aided Drug Design Techniques,"a doctoral student from abroad has been awarded one year of TÜBİTAK-supported training in Dr. Durdağı's laboratory under the TÜBİTAK-2216 Research Fellowship Program for International Researchers.